Focus on individual biotech companies and their pipelines rather than market volatility.
Look for undervalued companies with an enterprise value at or below one times peak sales.
Prioritize late-stage and commercial opportunities over preclinical or early-stage clinical trials.
Manage risk by diversifying your portfolio and avoiding overexposure to any single sector.
Regularly scan for opportunities but only invest when there's a compelling story and a favorable risk-reward profile.
00:00
Transcript
Episode notes
Jonathan Faison shares his approach to investing in biotech, the 'riskiest' sector (1:35). Recent lows and seeing through the volatility (4:10). Sector winners (9:20). Do sector ETFs make sense? (21:00) Updates on Sutro Biopharma and Voyager Therapeutics (24:15).